PaxMedica (PXMD) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsTrendsBuy This Stock PXMD vs. SMFL, AMPE, EFTR, ONCSQ, ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, and ACABWShould you be buying PaxMedica stock or one of its competitors? The main competitors of PaxMedica include Smart for Life (SMFL), Ampio Pharmaceuticals (AMPE), eFFECTOR Therapeutics (EFTR), OncoSec Medical (ONCSQ), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), and Atlantic Coastal Acquisition Corp. II (ACABW). These companies are all part of the "pharmaceutical products" industry. PaxMedica vs. Smart for Life Ampio Pharmaceuticals eFFECTOR Therapeutics OncoSec Medical 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Smart for Life (NASDAQ:SMFL) and PaxMedica (NASDAQ:PXMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends. Is SMFL or PXMD more profitable? Smart for Life's return on equity of 0.00% beat PaxMedica's return on equity.Company Net Margins Return on Equity Return on Assets Smart for LifeN/A N/A N/A PaxMedica N/A -3,167.89%-560.35% Does the MarketBeat Community prefer SMFL or PXMD? Smart for Life and PaxMedica both received 1 outperform votes by MarketBeat users. CompanyUnderperformOutperformSmart for LifeOutperform Votes1100.00% Underperform VotesNo VotesPaxMedicaOutperform Votes1100.00% Underperform VotesNo Votes Which has better valuation and earnings, SMFL or PXMD? PaxMedica has lower revenue, but higher earnings than Smart for Life. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmart for Life$11.11M0.00-$22.68MN/AN/APaxMedicaN/AN/A-$18.29MN/AN/A Which has more risk & volatility, SMFL or PXMD? Smart for Life has a beta of 1.57, indicating that its share price is 57% more volatile than the S&P 500. Comparatively, PaxMedica has a beta of -1.44, indicating that its share price is 244% less volatile than the S&P 500. Does the media favor SMFL or PXMD? In the previous week, Smart for Life's average media sentiment score of 0.00 equaled PaxMedica'saverage media sentiment score. Company Overall Sentiment Smart for Life Neutral PaxMedica Neutral Do institutionals and insiders have more ownership in SMFL or PXMD? 28.4% of Smart for Life shares are held by institutional investors. Comparatively, 4.9% of PaxMedica shares are held by institutional investors. 31.7% of Smart for Life shares are held by insiders. Comparatively, 1.0% of PaxMedica shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummarySmart for Life beats PaxMedica on 6 of the 7 factors compared between the two stocks. Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart PXMD vs. The Competition Export to ExcelMetricPaxMedicaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1,000.00$6.85B$5.55B$8.04BDividend YieldN/A2.95%5.09%4.22%P/E RatioN/A7.5022.7518.82Price / SalesN/A257.30403.97106.68Price / CashN/A65.8538.1834.62Price / BookN/A6.576.794.33Net Income-$18.29M$143.37M$3.22B$247.85M PaxMedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXMDPaxMedicaN/AN/AN/AN/A$1,000.00N/A0.002SMFLSmart for LifeN/A$0.00+33.3%N/A-100.0%$3,000.00$11.11M0.00110Gap UpAMPEAmpio PharmaceuticalsN/A$0.00flatN/A-99.8%$2,000.00N/A0.0020Analyst ForecastEFTReFFECTOR TherapeuticsN/A$0.00flatN/A-100.0%$1,000.00$3.55M0.0010ONCSQOncoSec MedicalN/AN/AN/AN/A$1,000.00N/A0.0040ATNFW180 Life SciencesN/A$0.01flatN/A-22.1%$0.00N/A0.007Gap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.02-4.5%N/AN/A$0.00N/A0.002AIMDWAinosN/A$0.09+9.6%N/AN/A$0.00$20,729.000.0040Gap DownALVOWAlvotechN/A$1.11-14.6%N/A-53.7%$0.00$489.68M0.004Short Interest ↑News CoverageGap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/A-78.3%$0.00N/A0.0015 Related Companies and Tools Related Companies SMFL Alternatives AMPE Alternatives EFTR Alternatives ONCSQ Alternatives ATNFW Alternatives LBPSW Alternatives AEHAW Alternatives AIMDW Alternatives ALVOW Alternatives ACABW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PXMD) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PaxMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PaxMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PXMD Stock Free PXMD Stock Alerts